3-Bromo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridine dihydrochloride

Catalog No. :
ACZAKC814
CAS No. :
1956382-38-9
Molecular Formula :
C7H9BrCl2N2
Molecular Weight :
271.97

IUPAC Name:3-bromo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridine dihydrochloride

3-Bromo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$195.00Login to see priceInquiryInquiry
250mg95%$293.00Login to see priceInquiryInquiry
1g95%$741.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridine dihydrochloride
IUPAC Name3-bromo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridine dihydrochloride
MDL No.MFCD22690189
Molecular FormulaC7H9BrCl2N2
Molecular Weight271.97
SMILESBrC1=CN=C(CNC2)C2=C1.[H]Cl.[H]Cl
InChI KeyYMFUAYBGAJPVIS-UHFFFAOYSA-N
Synonym3-Bromo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridine dihydrochloride;3-Bromo-5H,6H,7H-pyrrolo[3,4-b]pyridine dihydrochloride
CAS No.1956382-38-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACZAKC814 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZAKC814 route product structure diagram
    ACZAKC8141956382-38-9
Inquiry

2. ACZAKC814 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  6. Then
  7. ACZAKC814 route product structure diagram
    ACZAKC8141956382-38-9
Inquiry

Comments (0)